LPL Financial
STRO icon

LPL Financial’s Sutro Biopharma STRO Stock Holding History

LPL Financial’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-14,288
Closed -$124K – 6054
2025
Q3 		$124K Sell
14,288
-22,787
-61% -$194K ﹤0.01% 5461
2025
Q2 		$265K Sell
37,075
-1,918
-5% -$15.7K ﹤0.01% 4867
2025
Q1 		$254K Buy
38,993
+2,770
+8% +$43.6K ﹤0.01% 4693
2024
Q4 		$667K Buy
36,223
+9,233
+34% +$282K ﹤0.01% 3839
2024
Q3 		$934K Buy
26,990
+3,975
+17% +$156K ﹤0.01% 3465
2024
Q2 		$674K Buy
+23,015
New +$910K ﹤0.01% 3605

Other funds holding STRO

AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
MC
Merck & Co Kenilworth, New Jersey $349M AUM 146.07% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

LPL Financial's STRO Position: Q4 2025 in Review

LPL Financial sold out of Sutro Biopharma (STRO) in Q4 2025, closing a stake of 14,288 shares — an estimated $124K sold.

LPL Financial first reported a position in STRO in Q2 2024 and held it in 6 quarters. The position peaked at $934K in Q3 2024. 63 funds tracked by Wall St. Rank hold STRO as of Q4 2025.

  • LPL Financial reported no remaining Sutro Biopharma position as of Q4 2025 after selling out during the quarter.
  • LPL Financial sold 14,288 Sutro Biopharma shares in Q4 2025, an estimated $124K.
  • LPL Financial first reported a position in Sutro Biopharma in Q2 2024 and held it in 6 quarters.
  • LPL Financial's Sutro Biopharma position peaked at $934K in Q3 2024.
  • 63 funds tracked by Wall St. Rank held Sutro Biopharma as of Q4 2025.

Based on LPL Financial's 13F filing for Q4 2025, filed 11 Feb 2026.